The ASX has been very strong with not allowing covid type updates to be through their announcements, unless an actual sales deal, or price sensitive issue like LDX recent failure.
Quarterlies provide a great opportunity to update the market with progress, which helps to fill in a lot of knowledge gaps for shareholders.
Looking forward to this one as Ellume sales should be starting to ramp up, Eugeni sales should have commenced in select European countries along with an update on where TGA and associated testing is at.
Hopefully a rough timeline for the energy dept too.
Im expecting this will be the most positive quarterly we have seen for a long time.
Would be great to have a new CEO announced by then so we can hear from them as to why they have joined the company etc.
Quarterly Due End of Month, page-5
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.4¢ |
Change
0.002(9.09%) |
Mkt cap ! $59.14M | |||
| Open | High | Low | Value | Volume |
| 2.3¢ | 2.7¢ | 2.3¢ | $511.3K | 20.87M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 3685330 | 2.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.5¢ | 839726 | 3 |
View Market Depth
| Last trade - 16.10pm 22/05/2024 (20 minute delay) ? |
|
|||||
|
Last
2.5¢ |
Change
0.002 ( 19.1 %) |
||||
| Open | High | Low | Volume | ||
| 2.4¢ | 2.7¢ | 2.4¢ | 14992112 | ||
| Last updated 15.55pm 22/05/2024 ? | |||||
| ADO (ASX) Chart |